By Mary Stuart
Kinetic Concepts Inc. (KCI) headed the list of best-performing IPOs in 2004 by finishing the year with an almost...
KCI: In Wound Care, A Surfaces Company Goes Deep
Kinetic Concepts' 28-year overnight success story rests on an opportunistic acquisition designed to complement its core business in specialty beds designed to prevent or relieve wounds caused by patient immobility. In 1994, KCI acquired rights to the VAC (Vacuum Assisted Closure) Therapy System, a non-invasive wound closure device that uses controlled, localized negative pressure to help promote healing in chronic and acute wounds. VAC is now the company's principal growth driver, accounting for 71% of the company's revenues, and a growth rate of 28%. VAC has been everything that KCI hoped--and much more. But now, in order to penetrate the $3.3 billion markets that it is targeting, the company will have to move beyond the core hospital markets where it's been successful, to the more challenging extended care and home health care markets.
More from Archive
More from In Vivo
• By
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
• By
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
• By
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.